Albemarle Corporation
According to its February 28, 2018 SEC disclosure, Albemarle said, "We do not intent to continue doing such business in Iran." (SEC, "Form 10-K," 2/28/2018).
--
--
The US Government granted Albemarle Corporation a license to sell ibuprofin in Iran. (New York Times, "Licenses Granted to U.S. Companies Run the Gamut," 12/24/10)
Receive Iran News in Your Inbox.
Eye on Iran is a news summary from United Against Nuclear Iran (UANI), a section 501(c)(3) organization. Eye on Iran is available to subscribers on a daily basis or weekly basis.